Even though systemic clearance of midazolam currently is the preferred method for CYP3A4 phenotyping, it may have some important limitations in special populations, e.g., patients with obesity, as shown in the present study. Here, CYP3A4 is linked to obesity due to melanocortin 4 receptor deficiency.